Friday, 2 June 2023
Torrent Pharmaceuticals
Revenue up 16.9% at Rs 2,491 crore (Bloomberg estimate: Rs 2,474.3 crore)
Ebitda up 29.6% at Rs 727 crore (Bloomberg estimate: Rs 728.6 crore)
Ebitda margin at 29.2% vs 26.3% (Bloomberg estimate: 29.4%)
Net profit of Rs 287 crore vs net loss of Rs 118 crore (Bloomberg estimate: Rs 322.2 crore profit) The board approved raising Rs 5,000 crore via crore via debt.
The company will pay a final dividend of Rs 8 per share for the fiscal 2023.
India Daybook – Stocks in News
*P&G:* Net profit up 36.5% Rs 210.7 cr, Revenue up 8.9% at Rs 1,138.4 cr YoY *TVS Motors:* Net profit at Rs 536.6 cr vs poll Rs 520.0 c...
-
Ashok Leyland:* 14110 units versus 13273 units ( *Up 6.0%* ) Tata Motors:* 72600 units versus 76210 units ( *Down 4.7%* ) M&M Total:* ...
-
The company, which runs the fashion brand Killer, has entered a strategic partnership Board of Control for Cricket in India to become an off...
-
The IT company said subsidiary Comviva Technologies along with the company’s step-down subsidiary Comviva Technologies BV agreed to sell 0....